One of the sites provided by SCR for a Phase III study on CDAD having stringent inclusion/exclusion criteria was successfully pre screened 43 patients out of them 5 positive subjects within time limit.
SCR is coordinate and managed four sites in India sponsored by FDA, US.
SCR make executive sites for conduct the various upcoming/ongoing studies for prevention the many draw back during the studies.
SCR team also coordinate and support of naive sites and PIs which are enthusiasm for Clinical & medical research.
SCR team provides high quality of work, high subject retention and good subject follow for the managed studies.